Environmental lead exposure may aggravate Alzheimer’s pathology: ICMR-NIN study
Researchers at ICMR-NIN, Hyderabad, have found that environmental lead exposure can intensify cellular damage when combined with amyloid-β peptides, which…
Tag: Alzheimer
Eisai launches LEQEMBI for early Alzheimer’s disease treatment in India
Eisai has launched LEQEMBI (lecanemab) in India after receiving CDSCO approval, introducing the country’s first disease-modifying therapy for early Alzheimer’s…